Marketwatch Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-Shaw Admin January 27, 2020 It looks to build a pipeline of 28 biosimilars across global markets in three phases. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
